The World Economic Forum, KPMG, and Sanofi have proposed a new healthcare paradigm termed as Universal Health Coverage 2.0 (UHC2.0) to optimize resources and assure sustainability.
FREMONT, CA: World Economic Forum, KPMG, and Sanofi have proposed a new healthcare paradigm termed as Universal Health Coverage 2.0 (UHC2.0) to optimize resources and assure sustainability. UHC 2.0 normalizes care and wellbeing. Delivery and financing methods must be future-proof while Improving standards of care via life-course vaccination, diabetes management, and unusual disorders.
Physical vs. virtual healthcare infrastructure
The UHC 2.0 infrastructure prioritizes patient experience, resource efficiency, and equal access to technology and data. The rapid network expansion in APAC countries should be exploited to meet the rising healthcare demand. Apps and wearables may help identify, diagnose, and manage sickness.
Personalized therapy is more likely with digital health records. In APAC, where cultural norms and medical authority tend to render patients inert, encouraging active participation in healthcare choices may assist. Beyond development, UHC 2.0 needs peak performance.
Increasing data capture rates needs more infrastructure and capacity. General practitioners' training and comprehension must also be improved. The need for cross-border training and improved illness recognition is crucial.
Changes in social security and legislation that favour national programmes for rare illnesses. Nothing matters until and until we alter our behaviours today. Closer coordination throughout APAC is essential to address healthcare inequities, which might result in resource simplification and increased treatment availability. Certain patients' test findings may warrant a second opinion.
Participation in health Life-course vaccination (a low-cost strategy for UHC 2.0) Immunization throughout one's life is a low-cost preventative measure. It alleviates the burden of chronic diseases and inhibits the development of new ones. The Vietnamese government has partnered with companies to provide inexpensive HPV vaccinations in an effort to increase uptake, this strategy aided in the vaccine's community adoption. Apart from increasing vaccination rates, governments may foster ecosystem cooperation through using financial market surpluses such as social impact bonds SIBs may contribute to the improvement of preventative care by investing in diabetes prevention and treatment. Regular screening, basic treatment, and healthcare literacy will benefit even if the number of diabetes increases dramatically.
Diabetes management funding is increasing via SIBs and corporate philanthropy.
For example, SMBC and Mizuho Bank invested in Japan's SIB healthcare. While SIBs are a social investment for mainstream investors there needs to be a mix of systemic and personal incentives. Stakeholder benefits may compensate for accountability.
Using installment-style programs with many public and private partners might help fund uncommon illnesses. A pan-regional financing model for uncommon diseases is also being studied. The goal may be to standardize the uncommon illness matrix. To do so, they must focus on their own treatment needs, standardize care, and create legal frameworks for sharing resources and data. Crowdfunding is another legitimate international fundraising tool. Options like tax incentives and sin taxes are feasible only if they come from several sources.